| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d92c46f60af8af24e262b67381d7eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7abc1cf6b1775dc817ca8e252d9fd290 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
| filingDate |
1999-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2f7773e046945bf3e500a1dc4ace564 |
| publicationDate |
1999-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9938537-A1 |
| titleOfInvention |
METHODS FOR TREATING Th1-ASSOCIATED IMMUNE DISORDERS |
| abstract |
The invention encompasses methods of inhibiting an undesired Th1-mediated immune disorder, such as a Th1-mediated autoimmune disease, in a mammal suffering from or at risk of developing such a disorder by administering to the mammal a substantially pure dsRNA. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8299042-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015144714-A1 |
| priorityDate |
1998-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |